Recent advances in combination therapy by using chemotherapeutic drugs and small noncoding RNAs have highlighted the need for optimization of such agents to allow their carriage in a single delivery system. This protocol details the synthesis of a doxorubicin prodrug, where a NHS coupling reaction was used to sensitize the drug to the proteolytic activity of tumor microenvironments. The design of a lipid-modified miRNA by an S-S coupling reaction is also described. Modification of both, doxorubicin and miRNA, facilitated their simultaneous incorporation into mixed micelles for use in combination therapy against tumor cells.
CITATION STYLE
Costa, D. F., Sarisozen, C., & Torchilin, V. P. (2019). Synthesis of doxorubicin and miRNA stimuli-sensitive conjugates for combination therapy. In Methods in Molecular Biology (Vol. 1974, pp. 99–109). Humana Press Inc. https://doi.org/10.1007/978-1-4939-9220-1_8
Mendeley helps you to discover research relevant for your work.